Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
Patel AA, Yoon JJ, Johnston H, Davidson MB, Shallis RM, Chen EC, Burkart M, Oh TS, Iyer SG, Madarang E, Muthiah C, Gross I, Dean R, Kassner J, Viswabandya A, Madero-Marroquin R, Rampal RK, Guru Murthy GS, Bradley TJ, Abaza Y, Garcia JS, Gupta V, Pettit KM, Cursio JF, Odenike O.
Patel AA, et al. Among authors: chen ec.
Blood Adv. 2024 May 13:bloodadvances.2024012880. doi: 10.1182/bloodadvances.2024012880. Online ahead of print.
Blood Adv. 2024.
PMID: 38739724